<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03856983</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00450-57</org_study_id>
    <nct_id>NCT03856983</nct_id>
  </id_info>
  <brief_title>Benefits of Observing Point-light Displays in Postoperative Rehabilitation of the Total Knee Prosthesis.</brief_title>
  <acronym>LOARAL</acronym>
  <official_title>Benefits of Observing Point-light Displays in Postoperative Rehabilitation of the Total Knee Prosthesis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LOARAL project concerns patients who have undergone total knee arthroplasty to treat
      symptomatic osteoarthritis. Patient will be divided into two groups: a control group where
      patients will do standard rehabilitation and an experimental group where patients will do
      standard rehabilitation associated with the judgement of point-light display. The aim of this
      study is to validate the use of point-light display for the Rehabilitation of patients with a
      totalarthroplasty of the knee.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2020</start_date>
  <completion_date type="Anticipated">February 4, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 14, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the evaluation of the point light display relative to conventional rehabilitation</measure>
    <time_frame>Rehabilitation during 3 weeks</time_frame>
    <description>The time to realize the time up and go test will be assessed at inclusion and at the end of the program.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the evaluation of the point light display on functional recovery</measure>
    <time_frame>At the end of the program (3 weeks max)</time_frame>
    <description>Test score the time up and go and test score questionnary WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index, Bellamy et al., 1988).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the evaluation of the point light display on the detection and action recognition</measure>
    <time_frame>At the end of the program (3 weeks max)</time_frame>
    <description>Percentages of correct recognition of actions on the point light display</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the evaluation of the point light display on the feeling of self-efficacy personal</measure>
    <time_frame>At the end of the program (3 weeks max)</time_frame>
    <description>Test score questionnary of self-efficacy personal (Dumont et al., 2000).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Knee Surgery</condition>
  <condition>Rehabilitation</condition>
  <condition>Point Light Display</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group who will do usual rehabilitation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental group who will do usual rehabilitation and visualization of point-light human actions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Point light display</intervention_name>
    <description>Experimental group who will do usual rehabilitation and visualization of point-light human actions</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Volunteers over 18 years of age who have undergone knee surgery

        Exclusion Criteria:

          -  Any locomotor condition not due to knee surgery

          -  Uncorrected visual disturbances

          -  Comorbidity altering locomotion (history of stroke, neurological condition,
             inflammatory rheumatism)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>DELAUBIER Anne, Dr</last_name>
    <phone>05 49 44 44 54</phone>
    <email>anne.delaubier@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>BIDET-ILDEI Christel, Dr</last_name>
    <phone>05 49 45 46 97</phone>
    <email>christel.bidet@univ-poitiers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne DELAUBIER, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2019</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

